Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab′)2: A case study

Cancer

Volumn 91, Issue 9, 2001, Pages 1809-1813

  Cokgor, Ilkcan ^a   Akabani, Gamal ^a   Friedman, Henry S ^a   Friedman, Allan H ^a   Zalutsky, Michael R ^a   Zehngebot, Lee M ^a   Provenzale, James M ^a   Guy, Cynthia D ^a   Wikstrand, Carol J ^a   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

131I; Malignant melanoma; Mel 14 F(ab )2; Monoclonal antibody; Neoplastic meningitis; Treatment

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; IMMUNOGLOBULIN F(AB) FRAGMENT; IODINE 131; L SELECTIN ANTIBODY; METHOTREXATE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEARING LOSS; HUMAN; MELANOMA; MENINGIOMA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CHONDROITIN SULFATES; FEMALE; HUMANS; IODINE RADIOISOTOPES; L-SELECTIN; MELANOMA; MENINGITIS; MIDDLE AGED; RADIOPHARMACEUTICALS;

EID: 0035340633     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010501)91:9<1809::AID-CNCR1200>3.0.CO;2-L     Document Type: Article

References (24)

1. Radiation dose in isotope encephalography
2. Radiation dosimetry associated with the intrathecal administration of 131 I human serum albumin
3. Therapeutic irradiation of the central nervous system using intrathecal 90Y-DTPA
4. Dosimetry of several DTPA radiopharmaceuticals in cisternography
5. 169Yb-DTPA distribution and dosimetry in cisternography
6. A microcomputer algorithm for solving first-order compartmental models involving recycling
7. Current concepts in leptomeningeal metastasis
8. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
9. Clinical outcome in aggressively treated meningeal carcinomatosis
10. Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I study
11. The pharmacology and clinical use of methotrexate
12. Treatment of meningeal neoplasms
13. The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system
14. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma
15. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: A multicentre phase II study
16. Leptomeningeal metastases: Analysis of 31 patients with sustained off-therapy response following combined modality-therapy
17. Treatment of malignant meningeal disease with intrathecal thioTEPA. A phase II study
18. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis
19. Principles and applications of biologic therapy
20. Common human melanoma-associated antigen(s) detected by monoclonal antibodies
21. 2a in human glioma xenografts
22. 2 fragments with the α-particle-emitting nuclide astatine-211: Preservation of immunoreactivity and in vivo localizing capacity
23. 2 fragments of monoclonal antibody Mel-14
24. 2 fragment delivery to tumor in patients with glioma: Comparison of intracarotid and intravenous administration